
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 16, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 16, 2024
Language: Английский
Cytokine & Growth Factor Reviews, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 1, 2024
Language: Английский
Citations
5Journal of Virology, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 29, 2025
ABSTRACT The evolution of SARS-CoV-2 pathogenicity has been a major focus attention. However, the determinants are still unclear. Various hypotheses have attempted to elucidate mechanisms underlying viral pathogenicity, but definitive conclusion yet be reached. Here, we review potential impact all proteins in on pathogenic process and analyze effects their mutations evolution. We aim summarize which virus-encoded crucial influencing defined as disease severity following infection. Mutations these key proteins, virulence factors SARS-CoV-2, may driving forces behind pathogenicity. S protein can entry fusogenicity. such NSP2, NSP5, NSP14, ORF7a alter virus’s ability suppress host synthesis innate immunity. NSP3, NSP4, NSP6, N protein, NSP12 replication efficiency. combined NSP6 significantly reduce replication. In addition, various including ORF3a, ORF8, Spike E directly participate inflammatory process. modulate levels inflammation Collectively, influence by impacting immune evasion, capacity, level mediated conclusion, is likely determined multiple factors.
Language: Английский
Citations
0Heart Rhythm O2, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 1, 2025
Language: Английский
Citations
0Science Bulletin, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 1, 2025
Language: Английский
Citations
0International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(6), P. 2550 - 2550
Published: March 12, 2025
Even though in mid-2023 the World Health Organization declared end of public health emergency international concern status for COVID-19, many areas uncertainty about SARS-CoV-2 infection pathophysiology remain. Although last 4 years pharmaceutical industries widely invested development effective antiviral treatments and vaccines, large disparities their availability worldwide still exist, thus fostering investigation nutritional supplements as adjuvant therapeutic approaches disease management, especially resource-limited settings. During COVID-19 pandemic, vitamin D has been used an over-the-counter solution to improve evolution, thanks its known immunomodulatory anti-inflammatory actions. Ecological observational studies support a relationship between hypovitaminosis negative outcomes and, according this evidence, several research groups investigated role supplementation protecting from and/or improving evolution. This narrative review is intended offer insights into existing data on D’s biological effects respiratory infections, COVID-19. Furthermore, it will also brief overview complex interplay vaccine-elicited immune response, with special attention anti-COVID-19 vaccines.
Language: Английский
Citations
0Phytomedicine, Journal Year: 2025, Volume and Issue: unknown, P. 156697 - 156697
Published: March 1, 2025
Osteoarthritis is a chronic degenerative joint disease marked by chondrocyte senescence and extracellular matrix degradation. Vaccarin, flavonoid with anti-inflammatory antioxidant properties, has not been previously investigated for its therapeutic potential in osteoarthritis. To evaluate the of Vaccarin osteoarthritis elucidate underlying mechanisms. This study utilized vitro cultures RNA sequencing to identify relevant pathways, followed validation at genetic, protein, metabolic levels using multiple approaches. Additionally, effects were assessed vivo destabilization medial meniscus (DMM)-induced mouse model human cartilage samples from patients. effectively ameliorated both vitro. Transcriptomic indicated significant downregulation serum amyloid A2 (SAA2) expression following treatment. Multi-omics analysis, validated specimens, that SAA2 minimally secreted healthy articular but serves as crucial biomarker Asian populations. Mechanistically, inhibits c-Jun N-terminal kinase (JNK) phosphorylation, thereby reducing mitigating inflammation senescence. Notably, inflammatory conditions upregulate chondrocytes via JNK pathway. Elevated contribute mitochondrial dysfunction chondrocytes, leading increased reactive oxygen species (ROS) production exacerbating progression. identifies target suggests presents promising treatment avenue.
Language: Английский
Citations
0medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 10, 2024
Abstract Background Studies have reported that 5hmC features in cell-free DNA (cfDNA) could serve as early warning biomarkers for the occurrence and progression of COVID-19, well myocardial injury. However, its roles acute coronary syndrome (ACS) following COVID-19 infection not been fully studied. Methods Firstly, we used 5hmC-Seal technique to obtain genome-wide profiles from plasma cfDNA 24 ACS2N patients (individuals experiencing ACS onset within 2 months after infection), 28 ACS2W beyond 16 (patients with without infection). Secondly, performed GO, KEGG analysis on differentially expressed genes identified a series immune inflammation related genes. Thirdly, distribution cells different groups was studied by infiltration analysis. Finally, PPI network these identify potential key target Results In this study, firstly found there significant difference levels between patients, while significant. it neutrophils were abnormally activated group. gene phosphodiesterase 4D (PDE4D) be highly group differential validated external datasets. Conclusions Our study suggested markers extracted differentiate patients. addition, observed exhibited abnormal activation Further showed may affect development up-regulating PDE4D expression.
Language: Английский
Citations
1bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 10, 2024
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19 pandemic, has significantly impacted global health, emphasizing need to understand its pathogenicity and virulence mechanisms. SARS-CoV-2 disrupts alveolar epithelial barrier exacerbates airway inflammation, leading acute respiratory failure, but molecular details remain unclear. Additionally, infection causes neurological symptoms, potentially due weakly understood ability cross blood-brain barrier. The viral multifunctional Envelope (E) protein is crucial virulence, playing a key role in assembly, budding, release. E contains PDZ-binding motif (PBM) that interacts with host PDZ domain-containing proteins, affecting signaling pathways contributing pathogenicity. This study focuses on PBM disrupting barriers exacerbating inflammation. We generated recombinant mutant viruses lacking conducted both vitro vivo experiments elucidate impact fitness, pathogenicity, effects integrity. In vitro, mutants showed delayed replication reduced cytopathic effects. vivo, hamsters revealed PBM-deficient caused less weight loss, lower loads, indicating decreased Histological analyses confirmed damage these compared those infected wild-type virus. had impaired interactions tight junction proteins like ZO-1, PDZ-containing protein, maintaining Our findings also demonstrate does not play significant neuroinvasion during phase of infection, as evidenced by comparable RNA loads across brain regions hamsters, regardless presence. Histopathological transcriptomic further support this observation, suggesting primarily affects specific barriers. RNA-seq analysis lung brainstem from reveals modulates inflammatory immune responses, stronger tissue than brainstem. induce levels inflammation cytokine expression, PBM’s enhancing through activation such NF-κB TNF. Thus, plays critical SARS-CoV-2’s disruption cell junctions underscoring potential target therapeutic interventions.
Language: Английский
Citations
1The Lancet Respiratory Medicine, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 1, 2024
Language: Английский
Citations
0Frontiers in Cellular and Infection Microbiology, Journal Year: 2024, Volume and Issue: 14
Published: Dec. 6, 2024
Following COVID-19 outbreak with its unprecedented effect on the entire world, interest to coronaviruses increased. The causative agent of COVID-19, severe acute respiratory syndrome coronavirus - 2 (SARS-CoV-2) is one seven that pathogenic humans. Others include SARS-CoV, MERS-CoV, HCoV-HKU1, HCoV-OC43, HCoV-NL63 and HCoV-229E. viruses differ in their pathogenicity. SARS-CoV-2 are capable spread rapidly cause epidemic, while HCoV-229E mild disease. difference viral behavior due structural functional differences. All human possess four proteins: spike, envelope, membrane, nucleocapsid. Spike protein receptor binding domain crucial for entry host cell, where different receptors cell recruited by viruses. Envelope plays important role assembly, following cellular entry, contributes immune response. Membrane an abundant protein, contributing assembly pathogenicity virus. Nucleocapsid encompasses RNA into ribonucleocapsid, playing replication. present review provides detailed summary characteristics proteins from coronaviruses, could serve as a practical reference when compared, novel treatments proposed.
Language: Английский
Citations
0